Long Shortz with Orthocell: Adding Canada to its distribution list

Tylah Tully speaks to Orthocell (ASX:OCC) chair John Van Der Wielen after the company reached another major milestone.

Orthocell has now been granted access into the US$75 million Canadian market.

This news comes hot on the heels of its recent approval in Thailand and the US, and previous approvals in Australia, New Zealand and Singapore, opening the company up to a total addressable market of US$1.8 billion.

Watch the full interview to hear more.

 

This video was developed in collaboration with Orthocell. 

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.

Related Topics

Explore more

Explore more

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

Read The Guide